Quarterly report pursuant to Section 13 or 15(d)

Condensed Statements of Operations (Unaudited)

v3.20.1
Condensed Statements of Operations (Unaudited) - USD ($)
3 Months Ended 6 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Sep. 30, 2019
Sep. 30, 2018
Income Statement [Abstract]        
Revenue $ 153,500 $ 309,500
Cost of revenue 153,500 153,500 307,000 309,500
Gross loss (153,500) (307,000)
Operating expenses:        
Research and development 750,395 192,214 1,070,766 347,043
Selling, general and administrative 1,492,483 533,411 2,868,391 782,702
Total operating expenses 2,242,878 725,625 3,939,157 1,129,745
Loss from operations (2,396,378) (725,625) (4,246,157) (1,129,745)
Other income (expense):        
Other income 398 8,635
Interest expense (393,320) (238,532) (916,599) (363,114)
Change in fair value of warrant liability (11,482) (24,343) 136,326 (62,711)
Total other expense (404,802) (262,477) (780,273) (417,190)
Net loss $ (2,801,180) $ (988,102) $ (5,026,430) $ (1,546,935)
Net loss per share, basic and diluted: $ (0.24) $ (0.11) $ (0.46) $ (0.17)
Weighted average shares outstanding, basic and diluted: 11,625,368 9,040,547 11,314,802 9,040,547